A new U-M study assesses the short-term degrees of discomfort associated with prostate MRIs and biopsies, offering insights for future prostate cancer patient care.

A new subtype occurs in 7 percent of patients

Tumors with alterations in the CDK12 gene were more responsive to immunotherapy, suggesting a precision medicine approach.

Researchers identify a lncRNA that provides insight into a key driver of prostate cancer — and a potential target for future therapy.

A new model developed by Michigan Medicine researchers could change treatment guidelines for nearly two-thirds of men with localized prostate cancer.

Recently adjusted prostate cancer treatment guidelines based on new prostate research could affect two-thirds of men

Learn when active surveillance of low risk thyroid, prostate and breast cancer, may be appropriate and whether this approach could reduce overtreatment.

After his own treatment for prostate cancer, one father and husband encourages all men to learn more about the disease.

A new review finds that a family history of prostate cancer should not automatically exclude low-risk patients from an active surveillance approach.

Learn more about how Michigan Medicine specialists are combining new techniques to improve prostate cancer diagnosis.

A novel strategy to target a genetic anomaly that occurs in half of all prostate cancers may provide a path for developing new therapies against it.

Some genetic mutations linked to breast cancer also can affect men, but in a different way. A Michigan Medicine urologist explains the connection.

Prostate cancer screenings have dropped, but prostate cancer treatment remains high. Learn more about the overdiagnosis and overtreatment of prostate cancer.

U-M makes news

Rodney documented his prostate cancer treatment by taking a picture after every chemotherapy treatment. Learn more about Rodney's prostate cancer survival story.